KOL Engagement in Co-Commercialization | Acceleration Point | Resources

In co-commercialization agreements across the healthcare industry, engaging with Key Opinion Leaders (KOLs) is a central part of the strategy. Because every organization in a co-commercialization agreement may bring its own method of engagement, aligning these approaches into one coherent strategy is a recognized challenge. This article looks at that challenge and outlines a path toward a unified KOL engagement strategy supported by collaborative technology.

Co-commercialization is an arrangement in which two or more companies jointly promote and sell the same product under a single brand, sharing the associated responsibilities and rewards.

For a closer look at what makes this alignment difficult, see our companion article on the key challenges in KOL engagement for co-commercialization agreements.

Key Takeaways

Co-commercialization brings together partners that each have their own KOL engagement approach, and aligning those approaches is a recognized operational challenge.
Standalone tools such as PowerPoint and Excel limit real-time collaboration and transparency across partner organizations.
Clear communication and a mutual understanding of each partner's rationale are the foundation of an aligned KOL engagement strategy.
Compromise between partners is needed to find common ground and a consistent approach.
A shared platform gives every party visibility into KOL prioritization and joint engagement planning.

Why is aligning KOL engagement strategies difficult in co-commercialization?

Each organization in a co-commercialization agreement usually has its own well-established strategy for KOL engagement. These strategies, which can differ in terms of preferred communication channels, frequency of interactions, types of engagements, and even viewpoints on compliance, are often managed in standalone tools such as PowerPoint or Excel files. These tools are typically isolated and do not allow for real-time collaboration or transparency across different teams and organizations. Aligning these varying strategies into a coherent and consistent approach presents a substantial challenge.

Co-commercialization has also become more common. A Ropes & Gray survey of life-science collaboration agreements observed a more than fourfold increase in co-commercialization arrangements between 2017 and 2019, which raises the stakes for getting engagement alignment right. Research on biotech-pharma partnerships also finds that many falter because of structural and cultural misalignment rather than scientific failure, underscoring why a shared approach to engagement matters.

How do partners establish clear communication and mutual understanding?

The first step to overcoming this challenge lies in establishing clear and open lines of communication. Each organization needs to understand the others' approaches, their rationale, and their expected outcomes from KOL engagement planning. This shared understanding forms the foundation for creating an aligned strategy.

How do co-commercialization partners build a unified strategy?

Once there is clear communication and mutual understanding, the next step involves striking a balance between the differing strategies. This stage requires collaboration and compromise. All parties must be willing to adapt their approaches and find common ground that supports an effective, uniform approach to KOL engagement.

How does collaborative technology support aligned KOL engagement?

Traditional methods of managing KOL engagement strategies, such as PowerPoint and Excel files, often fall short here because they lack collaborative features. A platform like Kwello offers an alternative. It gives everyone involved in engaging with KOLs visibility into who has been prioritized, which goals the collaborative team has aligned to each expert, and a shared engagement plan they can build together. Bringing all parties onto a single platform supports transparency and helps the group work from the same set of priorities.

Conclusion

The challenge of aligning KOL engagement strategies in co-commercialization agreements is substantial. By fostering clear communication, promoting mutual understanding, and using collaborative technology like Kwello, partners can build a unified strategy that is adaptable and workable for everyone involved.

While each organization brings its own approach, the goal stays the same: to engage effectively with KOLs in a way that supports the shared objectives of the co-commercialization agreement. Getting there takes planning, a willingness to collaborate, and the right technology. The result is a coherent, unified approach that gives the partnership a solid foundation.

Frequently Asked Questions

What is co-commercialization in the pharmaceutical industry?
Co-commercialization is an arrangement in which two or more companies jointly promote and sell the same product under a single brand, sharing the associated responsibilities and rewards.

Why is aligning KOL engagement strategies difficult in co-commercialization agreements?
Each partner in a co-commercialization agreement usually has its own established approach to KOL engagement, differing in communication channels, interaction frequency, engagement types, and compliance viewpoints. These approaches are often managed in isolated tools like PowerPoint or Excel, which limits real-time collaboration and transparency across organizations.

How can co-commercialization partners align their KOL engagement strategies?
Partners can align their KOL engagement strategies by first establishing clear communication so each organization understands the others' approaches and rationale, then compromising to find common ground, and finally using a shared platform that gives every party visibility into KOL prioritization and joint engagement planning.

What role does collaborative technology play in unified KOL engagement?
Collaborative technology gives all partners a single place to see which KOLs have been prioritized, which goals are aligned to each expert, and how the joint engagement plan is taking shape, which supports transparency and helps partners work from the same priorities.

Curious how this applies to your organization? Let's talk.

Crafting a Unified Path: Aligning KOL Engagement Strategies in Co-Commercialization Agreements